Ata Stock News

NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorder

Whether you're into finances or just a fan of Shark Tank, chances are you know who Kevin O’Leary is. AKA Mr. Wonderful, the Canadian investor of Irish heritage is well known in the finance sp

DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the psychedelics space, composed of key thought leaders sharing i

- Führende gemeinnützige und kommerzielle Organisationen der psychedelischen Wissenschaft teilen die Vision von der Heilung psychischer Erkrankungen

The psychedelics sector received its latest sign of acceptance from Wall Street with famed investor Cathie Wood taking a position in Atai Life Sciences (NASDAQ: ATAI) through her ARKG ETF. The country

Cathie Wood-led Ark Investment Management on Wednesday further lowered its exposure in Twitter Inc (NYSE: TWTR), a day before the microblogging company is scheduled to report its financial results for

The clinical-stage biopharmaceutical company benefited from an increased interest in companies working on psychedelic therapies.

Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)

The Week In Psychedelics Last week saw some interesting developments from two of the largest publicly-traded companies in the psychedelics space: MindMed and Atai Life Sciences. MindMed announced that

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Atara To Sell Manufacturing Plant to Fuji's CDMO Unit For $100M Atara Biotherapeutics, Inc. (NASDAQ: A

ATAI Life Sciences (NASDAQ: ATAI) on Tuesday announced Invyxis, a new program to accelerate the company’s portfolio of compounds. What Happend: The clinical-stage biotechnology company focused on

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials.

New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) published encouraging data from a Phase II trial looking at ketamine-assisted ther

ATAI Life Sciences N.V. (ATAI) shares closed today at 1.0% above its 52 week low of $5.90, giving the company a market cap of $997M. The stock is currently down 18.5% year-to-date, down 68.0% over the past 12 months, and down 68.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 30.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 6.8% lower than its 5-day moving average, 17.2% lower than its 20-day moving average, and 51.0% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -19933.1% The company's stock price performance over the past 12 months lags the peer average by -164.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

• Ermöglicht die Ausweitung der klinischen Entwicklung von PCN-101 auf die USA